American Journal of Cardiovascular Drugs

Device Therapy for Heart Failure: When and for Whom?
pp. 147-153(7)
Authors: Shams, Omar F.; Ventura, Hector O.

Fixed-Dose Combination Therapy with Statins: Strengths, Limitations, and Clinical and Regulatory Considerations
pp. 155-160(6)
Author: Hennekens, Charles H.

Impact of Genetic Polymorphisms on the Efficacy of HMG-CoA Reductase Inhibitors
pp. 161-170(10)
Authors: Hutz, Mara H.; Fiegenbaum, Marilu

Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: Rationale and Place in Therapy
pp. 171-185(15)
Authors: Price, Laura C.; Howard, Luke S.G.E.

Management of ST-Elevation Myocardial Infarction: An Update on Pharmacoinvasive Recanalization
pp. 187-197(11)
Authors: Kashani, Amir; Giugliano, Robert P.

Statin Utilization Patterns for the Primary Prevention of Cardiovascular Events: A Retrospective Study in Patients with Diabetes Mellitus in Hong Kong
pp. 199-205(7)
Authors: Lee, Vivian W.Y.; Ho, Ivan C.H.; Chan, Windy S.Y.; Kai Yin Tam,; Lee, Kenneth K.C.

The Potential for Interaction between Warfarin and Coprescribed Medication: A Retrospective Study in Primary Care
pp. 207-212(6)
Authors: Snaith, Ailsa; Pugh, Lyn; Simpson, Colin R.; McLay, James S.